Febuxostat Improves Postprandial Glucose Regulation and Insulin Sensitivity in Hyperuricemic Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes: A Prospective Cohort Study
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s522154 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Shuang Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of Ch…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Febuxostat, Prediabetic State, Hyperuricemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
- Department of Pharmacy, Heze Municipal hospital, Heze, People's Republic of China.
- Department of Endocrinology and Metabolism, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, People's Republic of China.
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
ORCID-Profile: Shuang Liu, Ronger Gu
Zitieren
APA
Liu, S., Liu, Q., Gu, R., Wu, M., Meng, S., Yan, L., Chen, Q., Zhu, C., Chen, S., Xu, B., Liu, F., & Chen, H. (2025). Febuxostat Improves Postprandial Glucose Regulation and Insulin Sensitivity in Hyperuricemic Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes: A Prospective Cohort Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s522154
Vancouver
Liu S, Liu Q, Gu R, Wu M, Meng S, Yan L, et al. Febuxostat Improves Postprandial Glucose Regulation and Insulin Sensitivity in Hyperuricemic Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes: A Prospective Cohort Study. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s522154
BibTeX
@article{Liu2025,
author = {Liu, Shuang and Liu, Qingsong and Gu, Ronger and Wu, Mian and Meng, Shuo and Yan, Le and Chen, Qi and Zhu, Cuiling and Chen, Si and Xu, Bei and Liu, Fengjing and Chen, Haibing},
title = {Febuxostat Improves Postprandial Glucose Regulation and Insulin Sensitivity in Hyperuricemic Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes: A Prospective Cohort Study},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s522154}
}
EUVIMED